In 2025, the Durable Medical Equipment (DME) Market was valued at approximately USD 246.02 Billion. It is projected to grow at a CAGR of around 6.1% during the forecast period of 2026–2030, reaching an estimated USD 330.79 Billion by 2030.
The Global Durable Medical Equipment (DME) Market includes reusable medical equipment products intended for multiple or prolonged use for treatment, mobility, monitoring, recovery, and assistance for daily living. Designed for reuse, they are essential for both medical and non-medical care. The market includes, but is not limited to, patient transport, respiratory, therapeutic, safety, and extended-term monitoring devices. It typically doesn't include consumables, drugs, short-term disposable products, and non-product service revenue (for example, maintenance contracts).
Over the past few years, the market has shifted in response to the trend toward non-hospital care, including home care and care in the community. The growth in chronic conditions, population aging, and pressure to cut hospital costs have driven an increased need for reliable, long-lasting equipment that can be deployed outside of the clinical setting. But buyers also want quicker access to products, shorter lead times, e-commerce, and simpler devices to use. In turn, suppliers are delivering lighter, wireless, and patient-focused products, rather than those designed for institutional use only.
For market leaders, the business is more than a numbers game. The key to success is to know where the recurrence is, where the fastest-growing points of care are, and how reimbursement, procurement cycles, and channel economics impact revenue. It's the mix, not just the volume, that counts; supply and service capabilities are important too. Firms that develop portfolios in line with home care growth, the needs of older consumers, and effective distribution channels are well placed to sustain growth in 2030.
Key Market Insights
Research Methodology
Scope & definitions
Evidence collection (primary + secondary)
Triangulation & validation
Presentation & auditability
Global Durable Medical Equipment (DME) Market Drivers
Demand for connected care is being driven by an aging population.
An aging population drives demand for reliable devices geared to mobility, respiratory monitoring, and safe living. Health care institutions are transforming care pathways to incorporate connected equipment for remote monitoring and proactive care. And families want options that minimize trips to health-care providers while ensuring comfort at home.
Growth of home care is driving equipment purchases.
The ongoing shift from hospital care to home care is changing durable medical equipment purchasing, delivery, and maintenance. Health care providers now seek lightweight, easy-to-use devices that can be rapidly set up. Online systems for orders, remote troubleshooting and predictive maintenance are speeding up service and minimising downtime.
Smart monitoring is revamping patient care.
Smart monitoring systems are being adopted in healthcare to connect with durable medical equipment to enhance patient monitoring and efficiency. Connectivity-enabled devices can share device usage, maintenance, and health status information with providers. This helps preventable complications, promotes compliance, and facilitates equipment maintenance.
Global Durable Medical Equipment (DME) Market Restraints
Increasing demand doesn't prevent the global durable medical equipment market from experiencing some wrinkles. Insurance reimbursement issues can delay buying, and cost-based price sensitivity can squeeze margins across distribution channels. Supply chains are vulnerable to shortages, shipping costs, and inventory visibility. Administration approvals can impact product launches.
Global Durable Medical Equipment (DME) Market Opportunities
Increasing home care opportunities offer robust opportunities for teleconnected devices, rental programs, and subscription-based maintenance services. Global demographics drive replacements for mobility and respiratory equipment, with a pediatric focus driving premium segments. E-commerce may increase market share and transparency on profitability.
The core issue is not demand alone. It is demand under constraint.
Healthcare buyers face pressure to discharge patients earlier, reduce readmissions, and expand care at home. That lifts interest in mobility support, monitoring devices, and respiratory equipment. At the same time, many systems face budget controls and procurement scrutiny.
Supply chains remain more fragile than many assume. Route disruption, component concentration, freight swings, and compliance delays can slow replenishment. That matters when DME supports ongoing care, not optional consumption.
Capital allocation has also changed. Buyers now ask whether to hold inventory, dual-source supply, shift regions, or standardize vendors. The right answer differs by product class. A wheelchair is not bought like a respiratory device. A home-care monitor is not funded like hospital furniture.
This is why serious buyers need market clarity now: timing errors are expensive.
|
Claim type |
What good proof looks like |
What often goes wrong |
|
Growth outlook |
Clear scope, category splits, timeframe |
One headline number hides weak segments |
|
Demand strength |
Patient flow, aging trends, care setting shifts |
Assumes demographics equal purchases |
|
Margin potential |
Channel economics, pricing mix, service cost |
Ignores distributor pressure |
|
Supply resilience |
Multi-source map, lead-time evidence |
Treats one supplier as stable forever |
|
Regional opportunity |
Local reimbursement and route access |
Uses population size only |
|
Competitive position |
Installed base, contracts, repeat rates |
Counts brand awareness as share |
Many buyers overrate total market size and underrate category mix. A large market can still be unattractive if growth sits in segments where you lack access.
Another common error is double counting channel revenue and end-user demand. One device sold through a distributor should not be counted again at provider level.
Many forecasts also assume aging populations automatically convert into purchases. They do not. Funding access, clinician preference, and household affordability matter.
One-size regional claims fail too. High demand regions may have slow payment cycles, price caps, or difficult service coverage.
DURABLE MEDICAL EQUIPMENT (DME)MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2025 - 2030 |
|
Base Year |
2025 |
|
Forecast Period |
2026 - 2030 |
|
CAGR |
6.1% |
|
Segments Covered |
By Product Type, patient type. , end user, Distribution Channel and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Invacare Corporation, Drive DeVilbiss Healthcare, Medline Industries, LP, Cardinal Health, Inc., ResMed Inc., Koninklijke Philips N.V., Medtronic plc, Baxter International Inc., Stryker Corporation, GE HealthCare Technologies Inc., Sunrise Medical, Ottobock SE & Co. KGaA, GF Health Products, Inc., Arjo AB, and Omron Healthcare, Inc. |
Global Durable Medical Equipment (DME) Market Segmentation
• Introduction/Key Findings
• Mobility & Ambulatory Devices
• Monitoring & Therapeutic Devices
• Respiratory Equipment
• Bathroom Safety & Medical Furniture
• Others
• Y-O-Y Growth Trend & Opportunity Analysis
Mobility & Ambulatory Devices had a 34.2% share backed by wheelchairs, walkers, and scooters. The elderly demand repeated replacements. Rehabilitation demand ensured ongoing revenue growth across retail, hospital, and homecare markets globally in 2025, with growing service demand and stable procurement trends around the world.
Respiratory equipment was the fastest growing with an 8.9% CAGR in sleep apnea, COPD, oxygen therapy, and home monitoring. Purchases grew as providers sought to enhance discharge rates and plan for chronic disease care needs through 2030 in worldwide markets with growing patient populations today.
• Introduction/Key Findings
• Geriatric Population
• Adults
• Pediatric
• Others
• Y-O-Y Growth Trend & Opportunity Analysis
• Introduction/Key Findings
• Retail Medical Stores
• Online Channels
• Hospital-Based Distribution
• Others
• Y-O-Y Growth Trend & Opportunity Analysis
• Introduction/Key Findings
• Hospitals
• Home Healthcare Settings
• Nursing Homes & Long-Term Care Centers
• Rehabilitation Centers
• Others
• Y-O-Y Growth Trend & Opportunity Analysis
Hospitals dominated with a 38.6% share as acute care remained the primary purchaser of beds, lifts, monitors, and mobility devices. Centralized budgets and replacement demand sustained stable procurement of mature systems through 2025 globally today, now with consistent institutional demand levels overall.
Residential settings were the fastest growing, with a 9.6% CAGR as payers embraced cost-effective care options and patient preferences for home recovery. Remote monitoring and caregiver training boosted residential equipment use through 2030 globally across all regions, with continued strong growth ahead.
North America accounted for a head. 36% share supported by deep pockets, sophisticated home care infrastructure, and uptake of respiratory equipment. High provider spending power supported a superior product mix and demand for replacements across 2025 markets overall, with steady utilization rates and margins today, now.
Asia Pacific was the fastest growing with a 27% share backed by population aging, income growth, hospital builds, and increased access. Local production improvements and e-commerce increased affordability and availability through 2030 across key markets with continued strong growth regionally.
Latest Market News
On Jan 29, 2026, ResMed announced second-quarter fiscal 2026 revenue of USD 1.42 billion, an 11% year-over-year growth, and a 15% rise in diluted earnings per share (EPS) to USD 2.68. On Jan 29, 2026, operating cash flow was USD 340 million and gross margin was 61.8%.
Oct 30, 2025: ResMed reported first-quarter fiscal 2026 revenue of USD 1.34 billion, up 9% annually, and operating cash flow of USD 457 million. On Oct 30, 2025, diluted earnings per share (EPS) were USD 2.37, and gross margin was up 290 basis points to 61.5%.
Sep 25, 2025 Shareholder group VEB called for a Dutch investigation into Philips over its 2021 recall of sleep devices impacting some 15 million devices worldwide. Sep 25, 2025 documents also reminded me of Philips’ previous USD 1.1 billion settlement in the U.S. over the issue.
Sep 08, 2025: Philips said there was no new investigation underway in France relating to the 2021 recall of its respiratory devices, affecting some 15 million globally, including 350,000 in France. Sep 08, 2025: Philips shares fell 1.3% after earlier dropping almost 5%.
Apr 29, 2025: Philips posted 2% year-on-year comparable sales growth for the first quarter of 2025, with an adjusted EBIT A margin up 80 basis points to 8.6%. Apr 29, 2025, it also reported a 2% growth in orders, indicating continued demand in connected care and home equipment.
On Feb 19, 2025, Baxter sold its Kidney Care business to Carlyle for USD 3.8 billion, with a focus on its medical products and equipment businesses. On Feb 19, 2025, Baxter reported net proceeds of approximately USD 3.5 billion, after taxes and fees.
On Jan 30, 2025, ResMed delivered second-quarter fiscal 2025 revenue of USD 1.28 billion, up 10% year-on-year, and diluted earnings per share (EPS) of USD 2.34. On Jan 30, 2025, it also reported a non-GAAP gross margin of 59.2% and operating cash flow of more than USD 300 million.
On Jun 25, 2024, the company reached a USD 1.1 billion settlement in the US over the recalls of the sleep and respiratory devices announced in 2021. Jun 25, 2024: It follows the remediation of millions of devices and ongoing litigation for several years.
Key Players
Questions buyers ask before purchasing this report
Aging is important, but it is only one driver. Demand also depends on chronic disease prevalence, discharge practices, home-care adoption, reimbursement design, and caregiver availability. In some markets, older populations exist without matching purchasing power or payment support. A useful report separates demographic potential from monetized demand.
That depends on strategy. Mobility products often benefit from broad need. Respiratory devices can respond quickly to clinical demand shifts. Monitoring devices may gain from home-care models. Bathroom safety and furniture can be steadier but slower. Good buyers compare growth quality, margin structure, and replacement cycles.
Do not use population alone. Review channel access, payment timing, product registration rules, logistics reliability, service coverage, and local competition. Some smaller markets can be more profitable than larger but heavily constrained ones.
Because channel economics shape realized revenue. A strong product can still underperform if distributor incentives are weak, online pricing erodes margins, or hospital procurement cycles are long. Channel structure often decides speed to market.
Yes, in selected categories. Standardized and lower-complexity products may move online faster. Complex equipment still needs setup, training, and after-sales support. The winning model is often hybrid rather than fully digital.
Supplier concentration, reimbursement changes, and false demand signals. Buyers also underestimate service burdens after sale. In DME, selling the unit is only part of the economics.
Ask where growth sits, how recurring it is, and whether pricing is stable. Growth from temporary shortages or one-off tenders is less durable than growth tied to ongoing care models and replacement demand.
It reduces costly uncertainty. It helps compare segments, regions, channels, and risk exposure using a consistent market boundary. That supports better timing, cleaner assumptions, and fewer expensive strategic errors.
In 2025, the Durable Medical Equipment (DME) Market was valued at approximately USD 246.02 Billion. It is projected to grow at a CAGR of around 6.1% during the forecast period of 2026–2030, reaching an estimated USD 330.79 Billion by 2030.
The major drivers of the Global Durable Medical Equipment (DME) Market include the rising aging population, growing prevalence of chronic diseases, and increasing demand for long-term mobility, respiratory, and monitoring support. Growth is further supported by the rapid shift toward home healthcare settings, expanding use of smart connected medical equipment, and increasing preference for lightweight and user-friendly devices. In addition, stronger healthcare investments, growing online distribution channels, and recurring replacement demand for durable equipment are accelerating global market expansion
Mobility & Ambulatory Devices, Monitoring & Therapeutic Devices, Respiratory Equipment, Bathroom Safety & Medical Furniture, and Others are the segments under the Global Durable Medical Equipment (DME) Market by Product Type. Geriatric Population, Adults, and Pediatric are the segments by Patient Type. Retail Medical Stores, Online Channels, Hospital-Based Distribution, and Others are the segments by Distribution Channel. Hospitals, Home Healthcare Settings, Nursing Homes & Long-Term Care Centers, Rehabilitation Centers, and Others are the segments by End User.
North America is the most dominant region for the Global Durable Medical Equipment (DME) Market, holding approximately 36% share. This leadership is driven by advanced healthcare infrastructure, strong reimbursement systems, high adoption of home healthcare equipment, and widespread demand for technologically advanced medical devices. Asia Pacific holds around 27% share and is the fastest-growing region due to rising elderly populations, improving healthcare access, and increasing healthcare spending. Europe accounts for approximately 24% share, while South America and the Middle East & Africa contribute around 8% and 5%, respectively.
The key players in the Global Durable Medical Equipment (DME) Market include Invacare Corporation, Drive DeVilbiss Healthcare, Medline Industries, LP, Cardinal Health, Inc., ResMed Inc., Koninklijke Philips N.V., Medtronic plc, Baxter International Inc., Stryker Corporation, GE HealthCare Technologies Inc., Sunrise Medical, Ottobock SE & Co. KGaA, GF Health Products, Inc., Arjo AB, and Omron Healthcare, Inc.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
